A new blood test that looks for circulating tumor cells could significantly improve the diagnosis of prostate cancer and avoid unnecessary biopsies and treatments. A new blood test could help many people at risk of prostate cancer avoid unnecessary biopsies. Combining the new test with prostate specific antigen (PSA) results can yield a diagnosis of aggressive prostate cancer that is more than …
